The global neurovascular catheters market is gaining momentum as healthcare providers increasingly adopt minimally invasive procedures to treat complex neurological conditions, including ischemic stroke, brain aneurysms, and other cerebrovascular disorders. Neurovascular catheters play a critical role in modern interventional neurology by enabling physicians to navigate delicate blood vessels and deliver therapeutic devices to targeted areas of the brain. Growing awareness of early stroke treatment, improvements in catheter technology, and expanding access to specialized healthcare services are supporting market development.

The market outlook is closely linked to the increasing demand for advanced neurointerventional procedures, rising healthcare expenditure, and continued innovation in medical devices. For accurate market sizing, forecasts, and segment-level estimates, the figures published in the specified Grand View Research report should be used consistently rather than combining estimates from different research firms.

According to Grand View Research, the global neurovascular catheters market was valued at USD 3.2 billion in 2023 and is projected to grow from USD 3.9 billion in 2026 to USD 5.2 billion by 2030, registering a CAGR of 7.2% from 2024 to 2030. These projections highlight the growing role of neurovascular catheter technologies in the treatment of life-threatening cerebrovascular conditions. 

Download a free sample copy of the Neurovascular Catheters Market report to understand detailed coverage and inclusions in the final report

Key Market Projections and Dynamics

The global neurovascular catheters market is influenced by the growing incidence of neurological disorders, increased adoption of minimally invasive procedures, and ongoing improvements in medical device technology.

- Regional Dominance: North America held the largest regional market share, accounting for 35.3% of global revenue in 2023. The region benefits from established healthcare infrastructure, access to advanced neurointerventional treatments, experienced medical professionals, and the presence of leading medical device manufacturers. 

- Fastest-Growing Region: Asia Pacific is anticipated to experience significant growth over the forecast period. The regional market is projected to reach USD 1,129.5 million by 2030, expanding at a CAGR of 8.0% from 2024 to 2030. Improvements in hospital infrastructure, a large patient population, and increasing demand for advanced neurological treatments are supporting regional expansion. 

- Primary Growth Drivers: The increasing prevalence of stroke, brain aneurysms, and arteriovenous malformations is creating demand for effective neurovascular treatment options. In addition, minimally invasive endovascular procedures can provide an alternative to open surgery for selected conditions, potentially reducing surgical trauma and supporting recovery. Product innovation and broader awareness of early intervention are also contributing to market growth. 

Segment Insights

Product Type

The market is segmented into microcatheters, balloon catheters, access catheters, embolization catheters, and other catheter types. Each category serves specific purposes in diagnostic and therapeutic neurovascular procedures.

Embolization catheters represented the largest product segment in 2023, accounting for 27.48% of market revenue. These devices help physicians deliver embolic agents to targeted blood vessels to treat conditions such as brain aneurysms and abnormal vascular connections. Demand for embolization procedures and advances in catheter design are supporting this segment. 

Microcatheters are expected to register the fastest growth during the forecast period. Their small diameter, flexibility, and trackability enable clinicians to navigate narrow and complex blood vessels. They are used to deliver therapeutic devices and materials to specific locations within the neurovascular system. Improvements in coatings, materials, and catheter performance are expected to strengthen demand for these products. 

Application Areas

Neurovascular catheters are used in procedures involving embolic stroke, brain aneurysms, arteriovenous malformations, and other cerebrovascular conditions. Their ability to support targeted treatment through blood vessels makes them an important component of minimally invasive neurointerventional care.

The growing need for timely stroke management is encouraging healthcare providers to adopt technologies that support clot removal and vascular access. Catheters designed for aneurysm treatment also remain important because they help clinicians deliver coils, embolic materials, and other devices to the intended treatment site.

End-User Insights

Hospitals dominated the market in 2023, accounting for 55.29% of total revenue. Hospitals commonly have specialized neurovascular teams, advanced imaging equipment, emergency services, and catheterization facilities required for complex neurological interventions. Rising patient volumes and access to advanced treatment technologies are supporting hospital demand. 

Go Deeper! Ask Prism AI

about the Global Neurovascular Catheters Market. Get instant answers to

questions related to market sizing, growth drivers & their impact, and more.

Technological Trends and Innovations

Technology development is a major factor shaping the neurovascular catheters market. Manufacturers are working to improve navigation, flexibility, durability, and control in the challenging environment of intracranial blood vessels.

• Advanced Catheter Design: Improved catheter geometries and delivery systems can help clinicians access difficult-to-reach vascular areas during neurointerventional procedures.

• Innovative Materials and Coatings: Materials such as nylon and Pebax are used in catheter components to achieve a balance of flexibility, pushability, torque response, and support. Surface coatings can also help improve navigation through blood vessels.

• Stroke Intervention Technologies: Catheters designed to support aspiration thrombectomy and stent-retriever procedures are helping expand the range of endovascular stroke treatments available to clinicians.

Regional Market Highlights

North America remains a leading market because of its advanced healthcare infrastructure, established treatment pathways, and access to innovative medical technologies. The United States is a major contributor, supported by specialist care facilities and continued demand for stroke and aneurysm interventions.

Europe represents another important market, with growth supported by technological advancements and the adoption of minimally invasive procedures. 

Asia Pacific offers considerable growth opportunities as healthcare systems expand access to specialized procedures and invest in medical infrastructure. The region's projected 8.0% CAGR through 2030 reflects its potential as an important growth market. China and India are among the countries contributing to regional demand, although growth rates and market size differ by country. 

Competitive Landscape

The global neurovascular catheters market includes established medical technology companies competing through product innovation, portfolio expansion, strategic partnerships, and distribution networks. Key companies identified in the Grand View Research report include:

• Medtronic

• Nordson Corporation

• Stryker Corporation

• Terumo Corporation

• Integer Holdings Corporation

• Penumbra, Inc.

• Johnson & Johnson Services, Inc.

• Integra LifeSciences Corporation

Looking for more specific insights? Customize this report to suite your business needs